<DOC>
	<DOCNO>NCT02208856</DOCNO>
	<brief_summary>To assess safety , pharmacokinetics pharmacodynamics BIRB 796 BS escalate single dos , without 64 g fat breakfast one select dose .</brief_summary>
	<brief_title>Safety , Pharmacokinetics Pharmacodynamics Single Rising Doses Oral BIRB 796 BS Healthy Human Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male subject determine result screen Signed write informed consent accordance good clinical practice ( GCP ) local legislation Age &gt; = 18 &lt; = 45 year Broca &gt; = 20 % &lt; = +20 % Any finding medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant ot trial judge investigator Intake drug long halflife ( &gt; 24 hour ) ( = 1 month prior administration trial ) Use drug , might influence result trial ( = 10 day prior administration trial ) Participation another trial investigational drug ( =2 month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation &gt; 400 ml ( =1 month prior administration trial ) Excessive physical activity ( = 5 day prior administration trial ) Any laboratory value outside reference range clinical relevance ( exclusive ) total white cell count &gt; = 10 x 10**9/L , Creactive protein &gt; = 4.5 mg/L , haemoglobin &gt; 15 mg/dl protein urine dipstick History familial bleeding disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>